BEVERLY WANG: Open Payments
NPI 1902571805 · FOXBORO, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,767 in 176 payments from 38 companies in 2025. Trend: 2023 $2,274 · 2024 $3,128 · 2025 $3,767
Food & beverage: $3,767
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. | 38 | $834 |
| ABBVIE INC. | 21 | $327 |
| SK Life Science, Inc. | 10 | $278 |
| Lundbeck LLC | 11 | $211 |
| Biogen, Inc. | 10 | $204 |
| TG Therapeutics, Inc. | 4 | $195 |
| Eisai Inc. | 8 | $186 |
| Alexion Pharmaceuticals, Inc. | 8 | $160 |
| Mallinckrodt Hospital Products Inc. | 6 | $131 |
| Genentech USA, Inc. | 5 | $77 |
Products named: VYEPTI, Leqembi, BRIUMVI, TYSABRI, ULTOMIRIS, QULIPTA, ACTHAR, UBRELVY.
Industry payments across MA — which companies pay providers there.
